Get started
Author

Tushar B. Gajjar

Observed name: Tushar B Gajjar
ORCID: 0000-0001-9260-9662
Observed ORCIDs: 0000-0001-9260-9662, 0009-0009-7470-2009
OpenAlex ID: A5128818722
Neurovascular Uncoupling in Alzheimer’s and Parkinson’s Diseases: Mechanisms and Therapeutic Strategies
2026 · Akash Ved, Tushar B. Gajjar, et al. · Brain Sciences · 6
PDF
Plasmonic SPR sensor using SiO 2 /Ag-Au alloy/Cu/LaF/Graphene novel Kretschmann structure for SARS-CoV-2 detection: A theoretical study
2026 · Arun Uniyal, Amrindra Pal, et al. · Modern Physics Letters B · 6
Extracellular vesicles in cardiovascular disease: Biomarkers, therapeutic applications, and drug delivery strategies
2026 · Qamar Abuhassan, Amirali Salajegheh, et al. · Clinica Chimica Acta · 4
Injectable bioactive hydrogels as pharmacological drug delivery platforms for post-myocardial infarction cardiac repair: therapeutic cargo engineering, stimuli-responsive release mechanisms, and translational perspectives
2026 · Amr Ali Mohamed Abdelgawwad El-Sehrawy, Safa Alkhayyat, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2
Probiotics as modulators of the gut-derived incretin peptide axis in type 2 diabetes: GLP-1, GLP-2, and microbial metabolite signaling
2026 · Ghaleb Oriquat, Waleed K. Abdulsahib, et al. · PROTOPLASMA · 1
Multi-omic biomarkers in cardiovascular disease: Discovery to clinical translation
2026 · Tareq Nayef AlRamadneh, Waleed K. Abdulsahib, et al. · Clinica Chimica Acta · 1
CRISPR/Cas‑driven biosensing: molecular mechanisms and advances in diagnostics
2026 · Qamar Abuhassan, Hamzeh J. Al-Ameer, et al. · Molecular Biology Reports · 1
SUMOylation in Neural Health and Disease: From Cellular Homeostasis to Neurodegeneration
2026 · Ghaleb Oriquat, Ihsan K. Jasim, et al. · DNA and Cell Biology · 1
Epigenetic and post-transcriptional integration of lncRNAs and EZH2 in GI tumorigenesis
2026 · Suleiman Ibrahim Mohammad, Tushar B. Gajjar, et al. · Experimental Cell Research · 1
EGFR-targeted drugs and resistance mechanisms in non–small cell lung cancer: Molecular insights and emerging therapeutic strategies
2026 · Suleiman Ibrahim Mohammad, Asokan Vasudevan, et al. · DARU Journal of Pharmaceutical Sciences
Evaluation of heavy metals and their probabilistic Health risk in various cosmetics available in Saudi Arabian markets- a national comprehensive systematic review
2026 · Safwan Aladwan, Abdalkareem Jasim, et al. · International Journal of Environmental Health Research
Evaluation of heavy metals and their probabilistic Health risk in various cosmetics available in Saudi Arabian markets- a national comprehensive systematic review
2026 · Safwan Aladwan, Abdalkareem Jasim, et al. · Figshare
Bioactivatable conjugated nanocarriers for synergistic mRNA-mediated cancer immunotherapy
2026 · Noman Nazir, Tushar B. Gajjar, et al. · Journal of Pharmacology and Experimental Therapeutics
Therapeutic potential of apigenin in neurodegenerative diseases and brain health
2026 · Mohannad Aldiqs, Mansur Aliev, et al. · Molecular Biology Reports
Extracellular vesicles in neurodegenerative diseases: A new frontier in diagnosis and therapy
2026 · Suleiman Ibrahim Mohammad, Asokan Vasudevan, et al. · Behavioural Brain Research
Human health risk assessment of toxic and non-toxic elements in various oily, cream, and powder cosmetics in Arab countries- A systematic literature review
2026 · Safwan Aladwan, Abdalkareem Jasim, et al. · Journal of Trace Elements in Medicine and Biology
From contested target to context-aware node: A three-layer regulatory code for interpreting FTO's oncogene–tumor suppressor paradox in cancer
2026 · Ghaleb Oriquat, Sajida Hussein Ismael, et al. · Experimental Cell Research
Diagnostic biomarkers, prognostic signatures, and therapeutic resistance: shedding light on the dual role of autophagy in glioblastoma
2026 · Mohannad Aldiqs, Mansur Aliev, et al. · Clinica Chimica Acta
The effects of vitamin D supplementation on inflammatory biomarkers: an umbrella study of meta-analysis on randomized controlled trials
2026 · Chou-Yi Hsu, Hassan Youssef Hussein, et al. · Inflammopharmacology
Works count: 19
Citation count: 23
H-index: 3
I10-index:
Year
Topic
Type